Your email has been successfully added to our mailing list.

×
-0.0329920364050058 -0.0329920364050058 -0.0329920364050058 -0.0329920364050058 -0.0671217292377704 -0.055745164960182 -0.0773606370875997 -0.0728100113765643
Stock impact report

Cempra Withdraws Solithromycin Marketing Authorization Application in Europe

CEMPRA (CEMP) 
US:NASDAQ Investor Relations: ir.melinta.com/investor-relations
Company Research Source: GlobeNewswire
CHAPEL HILL, N.C., March 28, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for the acute care and community settings to meet critical medical needs in the treatment of infectious diseases, today announced that the company has withdrawn its marketing authorization application (MAA) seeking European Medicines Agency (EMA) approval of oral capsule and intravenous formulations of solithromycin for the treatment of community-acquired pneumonia in adults. Based on the Day 120 questions Cempra received from the EMA, the company believes additional data would be required. By withdrawing the MAA at this time, Cempra will conserve considerable financial resources, and it will allow the company to align its strategy to provide additional data to both the EMA and U.S. Food and Drug Administration (FDA) to support potential approval. “Our goal is to make solithromycin available in the EU to addr Show less Read more
Impact Snapshot
Event Time:
CEMP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CEMP alerts
Opt-in for
CEMP alerts

from News Quantified
Opt-in for
CEMP alerts

from News Quantified